Clinical trial · Observational
Liquid Biopsy of Head and Neck Cancer Patients in Blood and Saliva
NCT05122507CI-TRIAL-00065528KOHACINunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective study for therapy monitoring of locally advanced and metastatic head and neck cancer patients by detection of circulating tumor nucleic acids in peripheral blood and saliva
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Squamous Cell Carcinoma | Head and Neck Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Early recurrence detection lead time
- timeFrame
- Assessed up to 24 months
- description
- Lead time is defined as time between liquid-biopsy based recurrence detection and clinical recurrence or progression.
Secondary outcomes (2)
- measure
- Recurrence-free survival
- timeFrame
- Assessed up to 24 months
- description
- Recurrence-free survival
- measure
- Overall survival
- timeFrame
- Assessed up to 24 months
- description
- Overall survival
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Head and neck squamous cell carcinoma (HNSCC) * Written informed consent Exclusion Criteria: * Neoplasms other than HNSCC
References
Publications (0)
Data not yet available
No reference posted for this study.